IPHXU
IPHXUCIK 0002146310
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (RTX 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade IPHXU commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Sep 28, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statement of Operations (Unaudited)
| Description | Period from may 6, 2026 (inception) through june 30, 2026 |
|---|---|
| Formation, general, and administrative costs | 97,897 |
| Net loss | (97,897) |
| Basic and diluted weighted average Class B ordinary shares outstanding(1)(2) | 8,333,333 |
| Basic and diluted net loss per Class B ordinary share | (0.01) |
Condensed Balance Sheet (Unaudited)
| Description | June 30, 2026 |
|---|---|
| Prepaid expenses | 20,000 |
| Total Current Assets | 20,000 |
| Deferred offering costs | 49,719 |
| Total Assets | 69,719 |
| Liabilities and Shareholder’s Deficit: | |
| Current Liabilities | |
| Accrued expenses | 40,477 |
| Accrued offering costs | 49,719 |
| Promissory note related party | 52,420 |
| Total Current Liabilities | 142,616 |
| Commitments and Contingencies (Note 6) | |
| Shareholder’s Deficit | |
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding | — |
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued or outstanding | — |
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 9,583,333 shares issued and outstanding(1)(2) | 958 |
| Additional paid-in capital | 24,042 |
| Accumulated deficit | (97,897) |
| Total Shareholder’s Deficit | (72,897) |
| Total Liabilities and Shareholder’s Deficit | 69,719 |
Condensed Statement of Cash Flows (Unaudited)
| Description | Period from may 6, 2026 (inception) through june 30, 2026 |
|---|---|
| Net loss | (97,897) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares | 5,000 |
| General and administrative costs paid through promissory note related party | 52,420 |
| Changes in operating assets and liabilities: | |
| Accrued expenses | 40,477 |
| Net cash used in operating activities | — |
| Net change in cash | — |
| Cash, beginning of period | — |
| Cash, end of period | — |
| Supplemental disclosure of cash flow information: | |
| Deferred offering costs included in accrued offering costs | 49,719 |
| Prepaid expense paid by Sponsor in exchange for issuance of Class B ordinary shares | 20,000 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗